Bromoderma.

Bromoderma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Bromoderma. Abstract Text:

Bromoderma. Publishing Authors By Initials

For similar skin and connective tissue diseases: skin diseases research abstracts see: skin and connective tissue diseases: skin diseases research

PUBMED ID PMID:

MEDLINE DATE:

Bromoderma. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Archives of dermatology

VOLUME: 114

Page Numbers: 458-9

Journal Abbreviation: Arch Dermatol

ISSN: 0003-987X

DAY: 17

MONTH: Mar

YEAR: 1978

Bromoderma. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 372433

Bromoderma. Keywords Mesh Terms:

KEYWORDS: Skin Diseases

MESH TERMS: chemically induced

Chemical & Substance for Abstract: Bromoderma. Information

Substance Name: Bromides

Registry Number: 0

Grant and Affiliation Information for Bromoderma.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Arch Dermatol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Bromoderma Related Publications

• Bromoderma.
• CB1 receptor blockade and its impact on cardiometabolic risk factors: overview of the RIO programme with rimonabant.
• Cannabinoid-1 receptor antagonists in type-2 diabetes.
• Do thiazolidinediones increase the risk of congestive heart failure and cardiovascular death?
• Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program.
• Efficacy and safety of the weight-loss drug rimonabant.
• Medications in the kidney.
• Squatting amplifies pulse pressure increase with disease duration in patients with type 1 diabetes.
• The future of obesity: new drugs versus lifestyle interventions.
• [A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan): Exforge]
• [Anaesthetic risk related to cardiac autonomic neuropathy in diabetic patients]
• [Aspirin resistance in diabetic patients: laboratory entity or clinical reality?]
• [Blood glucose control and cardiovascular disease in patients with type 2 diabetes. Results of ACCORD, ADVANCE and VA-Diabetes trials]
• [Brain, a gluco-dependent organ: toxic effects of hypoglycaemia and hyperglycaemia]
• [Coronary drug-eluting stents in diabetic patients]
• [Diabetes mellitus: from clinical knowledge to public health concern.]
• [Does coffee protect against type 2 diabetes?]
• [Evaluation of insulinosecretion and insulinosensitivity.]
• [How I treat... by optimizing the blockade of the renin-angiotensin-aldosterone system]
• [In Process Citation]
• [In Process Citation]
• [Isolated tricuspid valve endocarditis as a cause of fever of unknown origin]
• [Peat-bath (40 degree C) tolerance after beta-adrenergic blockade]
• [Therapeutic impact of screening for myocardial ischemia among asymptomatic type 2 diabetic subjects]
• [Which place for a dual or triple inhibition of the renin-angiotensin-aldosterone system?]